Related Experiment Videos
[Hepatocholangiocarcinoma]
Z Gonciarz1, D Obrebska, P Besser
1VII Katedry i Kliniki Chorób Wewnetrznych Slaskiej Ak. Med. w Katowicach.
Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|October 1, 1993
Summary
This case report details an extremely rare mixed hepatocholangiocellular carcinoma in a 48-year-old man. Diagnosis was challenging due to combined hepatocellular and bile duct cancer features.
Area of Science:
- Hepatobiliary pathology
- Oncology
- Diagnostic imaging
Background:
- Hepatocellular carcinoma (HCC) and cholangiocellular carcinoma (CCC) are primary liver cancers with distinct origins and characteristics.
- Mixed hepatocholangiocellular carcinoma (HCCC) represents a rare entity combining features of both HCC and CCC.
- Accurate diagnosis is crucial for appropriate treatment and prognosis.
Observation:
- A 48-year-old male presented with a right hepatic lobe tumor detected via imaging.
- Elevated serum alpha-fetoprotein (AFP) and des-gamma-carboxyprothrombin (DCP) suggested HCC.
- Liver biopsy revealed bile duct origin (CCC), contrasting initial serological markers.
Findings:
- Histological examination of surgical and autopsy specimens confirmed distinct foci of both HCC and CCC.
- The tumor exhibited a mixed morphology, characteristic of hepatocholangiocellular carcinoma.
- The case highlights diagnostic discrepancies between serological markers and histological findings in mixed liver tumors.
Implications:
- This case underscores the diagnostic challenges posed by rare mixed liver cancers.
- It emphasizes the importance of integrating imaging, serological markers, and histology for accurate HCCC diagnosis.
- Understanding HCCC's rarity and diagnostic complexity is vital for clinical management and future research.